18F-FDG PET/CT对结外NK/T细胞淋巴瘤患者的预后分层
中期PET/CT按Deauville 5分法判读,多因素分析显示仅中期PET/CT结果是PFS和OS的独立预测因素。
要点
- 中期PET/CT按Deauville 5分法判读是ENKTL患者PFS和OS的独立预测因素。
- Deauville评分4/5分患者肿瘤负荷更重,血清LDH和β2-MG趋向升高。
- 单因素分析中年龄、分期、病灶部位、LDH、β2-MG、治疗前SUVmax及中期PET/CT均预测PFS。
核心结论
- 中期PET/CT对ENKTL患者显示潜在预测价值,按Deauville 5分法进行疗效评估可能提高预测准确性。
- 晚期(III/IV期)、LDH或β2-MG升高、中期PET/CT Deauville评分4-5分的患者更可能出现PFS和OS缩短。
研究设计与样本
- 中期PET/CT图像按Deauville 5分法判读,采用Kaplan-Meier法和Cox比例风险模型评估预后价值。
主要发现
- Deauville评分4/5分患者肿瘤负荷更重,血清LDH和β2-MG趋向升高。
- 单因素分析中,预测PFS的参数包括年龄(≤60 vs >60岁)、分期(I/II vs III/IV)、病灶部位(鼻 vs 鼻外)、LDH(正常 vs 升高)、β2-MG(正常 vs 升高)、治疗前SUVmax(≤8.3 vs >8.3)及中期PET/CT结果。
- 预测OS的因素包括分期、病灶部位、LDH、β2-MG及中期PET/CT结果。
- 多因素分析中,仅中期PET/CT按Deauville量表判读是PFS和OS的独立预测因素。
关键数值与推荐
- 中期PET/CT按Deauville 5分法判读,评分4/5分定义为高评分。
- 治疗前SUVmax以8.3为界值(≤8.3 vs >8.3)用于单因素分析。
临床怎么用
- 对ENKTL患者,中期PET/CT按Deauville 5分法判读可用于预后分层,高评分(4/5分)提示PFS和OS可能缩短。
- 结合分期、LDH、β2-MG及中期PET/CT Deauville评分综合评估患者预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The prognostic value of PET/CT for extranodal natural killer/T-cell lymphoma (ENKTL) patients is controversial. We sought to investigate the use of pretreatment and interim PET/CT in this disease. METHODS: Sixty-five patients diagnosed with ENKTL who underwent pretreatment (n = 53) and/or interim PET/CT scans (after 2-4 cycles of chemotherapy and/or radiotherapy, n = 33) were retrospectively enrolled. Interim PET/CT images were interpreted according to the Deauville 5-point scale. PET/CT results were assessed for their predictive value of progression-free survival (PFS) and overall survival (OS). Kaplan-Meier estimates were generated to evaluate the predictive value of clinical parameters and PET/CT scans for prognosis evaluation. The Cox proportional hazards model was performed to assess the potential independent predictors for PFS and OS. RESULTS: Patients with a high score (4/5) according to the Deauville scale had heavier tumor burdens and tended to have elevated serum LDH and β2-microglobulin (β2-MG). In univariate analysis, the following parameters were predictive of PFS: age (≤60 vs > 60 years), stage (I/II vs III/IV), lesion location (nasal vs extranasal), LDH (normal vs elevated), β2-MG (normal vs elevated), SUVmax before treatment (≤8.3 vs > 8.3), and interim PET/CT results. For OS, the predictive factors were composed of stage, lesion location, LDH, β2-MG, and interim PET/CT results. However, in multivariate analysis, only interim PET/CT scan interpreted by the Deauville scale remained as an independent predictor for both PFS and OS. CONCLUSIONS: Interim PET/CT scan displayed potential predictive value for ENKTL patients. Response assessment according to the Deauville 5-point scale may help to improve the accuracy of prediction. Patients with advanced stage (III/IV), elevated LDH or β2-MG, and a high Deauville score of 4 to 5 on the interim PET/CT scan were more likely to have reduced PFS and OS.
引用
- Qin C, Yang S, Sun X, et al. 18F-FDG PET/CT for Prognostic Stratification of Patients With Extranodal Natural Killer/T-Cell Lymphoma. Clin Nucl Med. 2019. PMID: 30624268. doi:10.1097/RLU.0000000000002440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。